Gentler PCOS Weight-Loss drug shows promise against standard treatment
NCT ID NCT07387679
Summary
This study compared two medications—myo-inositol and metformin—for treating obesity in women with polycystic ovary syndrome (PCOS). Researchers followed 60 women with PCOS to see which drug was more effective at reducing body mass index and which had fewer side effects. The goal was to help doctors choose the best treatment to improve weight and quality of life for their patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARIAN SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bahwal Victoria Hospital
Bahawalpur, Punjab Province, 63100, Pakistan
Conditions
Explore the condition pages connected to this study.